Clinical trial
Effect of 90% Effective Dose of Metaraminol in Supine and Left Tilt Positions on Cesarean Section:A Non-inferiority Trial
NCT05084599 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of 90% Effective Dose of Metaraminol in Supine and Left Tilt Positions on Cesarean Section:A Non-inferiority Trial
- Lead sponsor
- Peking University People's Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 12, 2022
- Completion date
- January 31, 2024
- Enrollment
- 124 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cesarean section complications